Clincosm LogoSign in Get a demo

mesothelioma

Showing 1 - 25 of 162
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Solid Tumor, CDKN2A, NSCLC Trial (Milademetan, Atezolizumab)

Withdrawn
  • Advanced Solid Tumor
  • +9 more
  • (no location specified)
Oct 16, 2023

Malignant Peritoneal Mesothelioma, Peritoneal Mesothelioma, Mesothelioma Trial in United States (Pemetrexed, Cisplatin,

Recruiting
  • Malignant Peritoneal Mesothelioma
  • +4 more
  • Chicago, Illinois
  • +10 more
Sep 21, 2023

Solid Tumor, Adult, Colorectal Cancer, NSCLC Trial in United States (A2B694, xT CDx with HLA-LOH Assay)

Not yet recruiting
  • Solid Tumor, Adult
  • +19 more
  • A2B694
  • xT CDx with HLA-LOH Assay
  • Duarte, California
  • +9 more
Sep 22, 2023

Non Small Cell Lung Cancer, Hepatocellular Carcinoma, Melanoma Trial in United States (MT-8421, Nivolumab)

Recruiting
  • Non Small Cell Lung Cancer
  • +10 more
  • Los Angeles, California
  • +4 more
Sep 5, 2023

NSCLC, Mesothelioma, Thymoma Trial in Breda, Dordrecht (Folinic acid)

Recruiting
  • NSCLC
  • +2 more
  • Folinic acid
  • Breda, Noord Brabant, Netherlands
  • +1 more
Aug 17, 2023

Mesothelioma, Malignant Mesothelioma (MM), Early-stage Mesothelioma Trial run by the National Cancer Institute (NCI)

Not yet recruiting
  • Mesothelioma
  • +5 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 1, 2023

Mesothelioma Trial in Durham, Houston (Durvalumab / tremelimumab, Platinum cisplatin or carboplatin and pemetrexed chemo plus

Not yet recruiting
  • Mesothelioma
  • Durvalumab / tremelimumab
  • Platinum cisplatin or carboplatin and pemetrexed chemotherapy plus durvalumab/tremelimumab
  • Durham, North Carolina
  • +1 more
Jul 5, 2023

Patients With Mesothelioma

Not yet recruiting
  • Mesothelioma
    • (no location specified)
    Apr 21, 2023

    Mesothelioma Trial (Magnesium sulfate, Normal Saline)

    Not yet recruiting
    • Mesothelioma
    • Magnesium sulfate
    • Normal Saline
    • (no location specified)
    Feb 15, 2023

    Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer Trial in United States (PRO1184)

    Recruiting
    • Ovarian Cancer
    • +8 more
    • Scottsdale, Arizona
    • +11 more
    Jan 31, 2023

    Malignant Pleural Mesothelioma, Mesothelioma Trial in Tampa (Cisplatin, Methotrexate, Gemcitabine)

    Active, not recruiting
    Has Results
    • Malignant Pleural Mesothelioma
    • Mesothelioma
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    Jan 5, 2023

    Cancer, Cancer, Lung, Cancer of Lung Trial in Worldwide (UV1 vaccine + leukine, ipilimumab, nivolumab)

    Active, not recruiting
    • Cancer
    • +6 more
    • UV1 vaccine + leukine
    • +2 more
    • Perth, Australia
    • +6 more
    Jan 23, 2023

    Mesothelioma Patients and Their Family Members With Germline

    Recruiting
    • Mesothelioma
    • Families
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 20, 2023

      Advanced Cancer, Anal Carcinoma, Anal Cancer Trial in Worldwide (pembrolizumab)

      Recruiting
      • Advanced Cancer
      • +24 more
      • pembrolizumab
      • Los Angeles, California
      • +21 more
      Jan 18, 2023

      Cutaneous Melanoma, NSCLC, Colorectal Tumors Trial in Denver (SGN-BB228)

      Recruiting
      • Cutaneous Melanoma
      • +4 more
      • Denver, Colorado
        Sarah Cannon Research Institute at HealthONE - Denver
      Jan 17, 2023

      Pancreatic Cancer, Hepatocellular Cancer, Squamous Cell Cancer (SCC) Trial in United States (TAK-500, Pembrolizumab)

      Recruiting
      • Pancreatic Cancer
      • +9 more
      • Duarte, California
      • +6 more
      Jan 17, 2023

      Mesothelioma, Uveal Melanoma, Renal Cell Carcinoma Trial in Gainesville, Miami, Orlando (Niraparib)

      Completed
      • Mesothelioma
      • +3 more
      • Gainesville, Florida
      • +2 more
      Jan 4, 2023

      Gastric Cancer, Renal Cell Carcinoma, Melanoma Trial in United States (HFB200301)

      Recruiting
      • Gastric Cancer
      • +8 more
      • Scottsdale, Arizona
      • +9 more
      Dec 22, 2022

      Advanced Solid Tumors, Glioblastoma, Soft Tissue Sarcoma (Excluding GIST) Trial in Boston, Madrid, Sevilla (Lurbinectedin,

      Recruiting
      • Advanced Solid Tumors
      • +11 more
      • Boston, Massachusetts
      • +4 more
      Dec 12, 2022

      Advanced Solid Tumor, MSI-H/dMMR Tumors, Cutaneous Squamous Cell Carcinoma Trial in Worldwide (INCB099280)

      Recruiting
      • Advanced Solid Tumor
      • +11 more
      • Boston, Massachusetts
      • +30 more
      Dec 1, 2022

      Melanoma, Breast Carcinoma, Hepatocellular Carcinoma Trial in United States (XmAb20717)

      Completed
      • Melanoma
      • +27 more
      • XmAb20717
      • Los Angeles, California
      • +16 more
      Nov 29, 2022

      Triple Negative Breast Cancer, Hormone-Resistant Breast Cancer, Non Small Cell Lung Cancer Trial in Baltimore (AG-01 Compound)

      Recruiting
      • Triple Negative Breast Cancer
      • +3 more
      • AG-01 Compound
      • Baltimore, Maryland
        University of Maryland Greenebaum Comprehensive Cancer Center
      Nov 16, 2022

      Mesothelioma, Pleural Mesothelioma, Wilms Tumor Trial in United States (Galinpepimut-S, Nivolumab, Sargramostim)

      Active, not recruiting
      • Mesothelioma
      • +2 more
      • Galinpepimut-S
      • +2 more
      • Basking Ridge, New Jersey
      • +5 more
      Nov 23, 2022

      Mesothelioma Trial in Worldwide (IAG933)

      Recruiting
      • Mesothelioma
      • Chicago, Illinois
      • +12 more
      Nov 17, 2022

      Mesothelioma Trial in United Kingdom (Nivolumab, Placebo)

      Active, not recruiting
      • Mesothelioma
      • Dundonald, Belfast, United Kingdom
      • +23 more
      Nov 16, 2022